The dual role of ion channels in diabetic kidney disease: a translational paradigm for biomarkers and target discovery - reviews and prospects.
Understanding how kidney disease varies between diabetic patients could shift treatment from one-size-fits-all to personalized approaches.
The clinical heterogeneity of diabetic kidney disease (DKD) poses a major challenge to current treatment strategies. Finally, we propose a phased, multi-stakeholder roadmap from biomarker discovery to clinical integration, aiming to shift DKD management from a "one-size-fits-all" approach to individualized precision therapy.
What the study was
- Study design
- Observational/unspecified
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- American journal of translational research
Why it surfaced
Score 6/10 [PROMISING_PRELIMINARY]: Observational review (Journal Article) matched 'Early cancer detection (liquid biopsy, ctDNA, cfDNA)' via cfDNA/biomarker terms in abstract, but article focus is diabetic kidney disease precision therapy — EARLY_CANCER_DETECTION flag removed as conservative correction. Components — novelty:2/3, relevance:2/3, design:1/2, population:1/2. Confidence: medium. Conservative scoring applied per v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.